Welcome to our dedicated page for Soren Acquisition SEC filings (Ticker: SORNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SORNW SEC filings page is dedicated to regulatory documents related to the redeemable warrants of Soren Acquisition Corp., a blank check company formed to pursue a business combination. Company disclosures explain that Soren Acquisition Corp. aims to complete a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar transaction, with a stated focus on healthcare targets.
Although no specific SEC filings are listed here in the provided data, Soren Acquisition Corp. has filed a registration statement covering its units, Class A ordinary shares, and warrants, which was declared effective by the U.S. Securities and Exchange Commission. That registration statement and related prospectus describe the structure of the SORNU units, the SORN ordinary shares, and the SORNW warrants, including the exercise terms for each whole redeemable warrant.
On Stock Titan, this page is designed to surface Soren Acquisition Corp.’s SEC submissions as they become available from EDGAR, including registration statements and, over time, periodic and transaction-related reports that may discuss the company’s search for a healthcare-focused business combination. Users can review these documents to understand how the company presents its objectives, capital structure, and the rights associated with its warrants.
AI-powered tools on the platform can assist by summarizing lengthy filings, highlighting key terms related to SORNW warrants, and helping readers interpret complex sections of registration statements or future reports connected to Soren Acquisition Corp.’s business combination efforts.
Soren Acquisition Corp. Schedule 13G discloses that Soren Holdings LLC and Arghavan Di Rezze report beneficial ownership of 8,433,333 Ordinary Shares, representing 24.3% of the issuer's Ordinary Shares. The holdings are held directly by the Sponsor and indirectly by Ms. Di Rezze as managing member; Ms. Di Rezze disclaims beneficial ownership except for any pecuniary interest. The filing cites 34,733,333 Ordinary Shares outstanding as of March 24, 2026 for the percentage calculation.